AIDSVAX B/B Trial Statistics
AIDSVAX B/B Trial Statistics
- Volunteers completing three doses: 5,009
- Placebo recipients: 1,679
- AIDSVAX B/B recipients: 3,330
- White volunteers: 4,185
- Hispanic volunteers: 326
- Non-white volunteers: 498
- Black volunteers: 314
- Annual study infection rate: 2.7%
Approximate efficacy (after at least 3 primary doses):
— All volunteers: 3.8% (p-value = 0.76)
— Non-white volunteers: 67% (p-value < 0.01)
— Black volunteers: 78% (p-value < 0.02)
AIDSVAX B/B Trial StatisticsSubscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.